174 related articles for article (PubMed ID: 618775)
1. Interaction of ergot alkaloids with dopaminergic receptors in the rat striatum and nucleus accumbens.
Spano PF; Trabucchi M
Gerontology; 1978; 24 Suppl 1():106-14. PubMed ID: 618775
[TBL] [Abstract][Full Text] [Related]
2. Long-term effect of ovariectomy on dopamine-stimulated adenylate cyclase in rat striatum and nucleus accumbens.
Kumakura K; Hoffman M; Cocchi D; Trabucchi M; Spano PF; Müller EE
Psychopharmacology (Berl); 1979 Mar; 61(1):13-6. PubMed ID: 220653
[TBL] [Abstract][Full Text] [Related]
3. Ergot alkaloids and cyclic nucleotides in the CNS.
Trabucchi M; Hofmann M; Montefusco O; Spano PF
Pharmacology; 1978; 16 Suppl 1():150-55. PubMed ID: 205889
[TBL] [Abstract][Full Text] [Related]
4. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
Memo M; Pizzi M; Missale C; Carruba MO; Spano PF
Neuropharmacology; 1987 May; 26(5):477-80. PubMed ID: 2955241
[TBL] [Abstract][Full Text] [Related]
5. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
Govoni S; Lucchi L; Missale C; Memo M; Spano PF; Trabucchi M
Brain Res; 1986 Aug; 381(1):138-42. PubMed ID: 3756492
[TBL] [Abstract][Full Text] [Related]
6. Binding interactions of ergot alkaloids with monoaminergic receptors in the brain.
Goldstein M; Lew JY; Hata F; Lieberman A
Gerontology; 1978; 24 Suppl 1():76-85. PubMed ID: 22480
[TBL] [Abstract][Full Text] [Related]
7. Ergot alkaloids inhibit 3H-naloxone binding to opiate receptors in the rat striatum and hippocampus.
Kosar E; Sumová A; Jakoubek B
Physiol Bohemoslov; 1986; 35(4):334-9. PubMed ID: 3020603
[TBL] [Abstract][Full Text] [Related]
8. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
Cools AR; van Rossum JM
Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
[No Abstract] [Full Text] [Related]
9. Dopamine receptors in rat striatum and nucleus accumbens; conformational studies using rigid analogues of dopamine.
Woodruff GN; Watling KJ; Andrews CD; Poat JA; McDermed JD
J Pharm Pharmacol; 1977 Jul; 29(7):422-7. PubMed ID: 19581
[TBL] [Abstract][Full Text] [Related]
10. Dopamine-sensitive adenylate cyclase in homogenates of rat nucleus accumbens: structure-activity studies and effects of agonists and antagonists.
Watling KJ; Woodruff GN; Poat JA
Eur J Pharmacol; 1979 Jun; 56(1-2):45-9. PubMed ID: 38129
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of sulfated cholecystokinin on DA-sensitive adenylate cyclase in two areas of the rat nucleus accumbens.
Studler JM; Reibaud M; Herve D; Blanc G; Glowinski J; Tassin JP
Eur J Pharmacol; 1986 Jul; 126(1-2):125-8. PubMed ID: 3758156
[TBL] [Abstract][Full Text] [Related]
12. Ergocryptine and other ergot alkaloids stimulate the release of [3H]dopamine from rat striatal synaptosomes.
Rowell PP; Larson BT
J Anim Sci; 1999 Jul; 77(7):1800-6. PubMed ID: 10438027
[TBL] [Abstract][Full Text] [Related]
13. Further evidence that 3H-cis(Z)flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum.
Hyttel J
Psychopharmacology (Berl); 1980 Jan; 67(1):107-9. PubMed ID: 6768074
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
[TBL] [Abstract][Full Text] [Related]
15. Effect of morphine on dopamine-sensitive adenylate cyclase activity of nucleus accumbens.
Iwatsubo K
Jpn J Pharmacol; 1977 Dec; 27(6):903-5. PubMed ID: 609155
[No Abstract] [Full Text] [Related]
16. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor profile of co-dergocrine (Hydergine) and its components.
Markstein R
Eur J Pharmacol; 1982 Dec; 86(2):145-55. PubMed ID: 6297930
[TBL] [Abstract][Full Text] [Related]
18. Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase.
Abbracchio MP; Colombo F; Di Luca M; Zaratin P; Cattabeni F
Pharmacol Res Commun; 1987 Apr; 19(4):275-86. PubMed ID: 2889222
[TBL] [Abstract][Full Text] [Related]
19. Thyrotrophin releasing hormone stimulates release of [3H]-dopamine from slices of rat nucleus accumbens in vitro.
Kerwin RW; Pycock CJ
Br J Pharmacol; 1979 Nov; 67(3):323-5. PubMed ID: 115532
[TBL] [Abstract][Full Text] [Related]
20. Effects of ergots on adenylate cyclase activity in the corpus striatum and pituitary.
Schmidt MJ; Hill LE
Life Sci; 1977 Mar; 20(5):789-97. PubMed ID: 15714761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
